| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.22M | 21.42M | 14.05M | 14.86M | 17.02M | 17.82M |
| Gross Profit | 6.12M | 6.12M | 2.82M | 3.23M | 4.51M | 3.55M |
| EBITDA | 1.78M | 1.76M | -990.00K | 308.00K | 1.38M | 944.00K |
| Net Income | 1.83M | 1.73M | -1.01M | -44.00K | 1.17M | 685.00K |
Balance Sheet | ||||||
| Total Assets | 7.70M | 8.60M | 6.50M | 8.71M | 8.88M | 8.46M |
| Cash, Cash Equivalents and Short-Term Investments | 3.71M | 3.37M | 2.05M | 4.79M | 5.33M | 4.92M |
| Total Debt | 701.00K | 538.00K | 753.00K | 1.05M | 426.00K | 733.00K |
| Total Liabilities | 3.06M | 3.76M | 3.10M | 3.51M | 2.86M | 3.18M |
| Stockholders Equity | 4.63M | 4.85M | 3.40M | 5.19M | 6.02M | 5.28M |
Cash Flow | ||||||
| Free Cash Flow | 2.04M | 2.16M | -1.51M | 692.00K | 1.07M | 1.29M |
| Operating Cash Flow | 2.10M | 2.22M | -1.47M | 701.00K | 1.21M | 1.33M |
| Investing Cash Flow | -53.00K | 339.00K | 54.00K | 93.00K | -24.00K | 80.00K |
| Financing Cash Flow | -1.21M | -1.24M | -1.33M | -1.32M | -777.00K | -332.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £2.38B | 10.91 | 42.93% | 2.05% | 51.50% | 11.62% | |
72 Outperform | £50.55M | 14.63 | 38.65% | 2.69% | 30.01% | 138.65% | |
68 Neutral | £3.24B | 20.00 | 17.42% | 2.43% | 21.86% | 0.86% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £187.99M | 18.70 | 4.57% | 3.01% | -31.46% | 297.44% | |
52 Neutral | £29.55M | -2.77 | -18.74% | ― | -5.84% | 55.30% |